Inflexion

Five key things mid-market CEOs should know in 2025 🏆 In today’s dynamic environment, staying ahead is critical for success. As we look towards 2025, we have summarised the five key areas that we believe should be at the top of the agenda for mid-market CEOs: 🌟Building high-performance teams 🌟Resilience in the face of a turbulent world 🌟Increased opportunities to grow through M&A 🌟Transforming with AI 🌟Sales force effectiveness Discover how we can back your ambition at www.inflexion.com #backingambition #acceleratinggrowth #championinginnovation

Inflexion is committed to #diversity within teams, so it recently invited its portfolio to learn how some businesses promote diverse #talent pipelines. 🌟 Learn from our portfolio companies Sparta Global, CNX Therapeutics, ANS Group and Medik8 about the innovative ways they hire, train and deploy diverse talent. Read more here: https://lnkd.in/exiscXg5 #backingambition #promotingtalent #encouragingdiversity Purnima Sen BA. MA. MBA Jessica Dall Tom Robinson Freddy West

Inflexion had another strong year in 2024 with nine new investments and five new realisations announced. We also supported 60 portfolio acquisitions across 12 countries and six continents. The firm raised £2.7bn in fresh capital and continued its European expansion with the opening of an office in Frankfurt. We’d like to thank our partners and colleagues for their support during the year and we look forward to more exciting partnerships in 2025! #BackingAmbition #AcceleratingGrowth

Huge congratulations to our portfolio company BES Group on completing their first European acquisition, Netherlands-based ECH Group. 👏 https://lnkd.in/eZgh3YJy

⭐ Inflexion news - December Highlights ⭐ Here are just a few key milestones from the past month: 👏 We announced two new investments. 🎧 We released the latest Inflexion Point podcast with an interview featuring Medik8 Founder, Elliot Isaacs. (https://lnkd.in/eHAZzEC9) 🚀 Inflexion portfolio companies TC Group, Easyfairs and Ocorian celebrated acquisitions, while Sparta Global, ANS Group and K2 Partnering Solutions celebrated awards. 🔎 We took a deep dive into using data and #AI to accelerate sales growth, discussed the increasing complexities of clinical trials for #pharmaceutical companies, as well as the successful carve-out of GRC. You can see the full highlights on the Inflexion website: https://lnkd.in/eZVy6wkH Thank you to everyone for your support throughout 2024. We look forward to an exciting 2025 and wish you a wonderful festive season from all of us at Inflexion! 🎄 #BackingAmbition #AcceleratingGrowth

Inflexion is pleased to announce that it has invested in Mecenat, a leading closed user group consumer loyalty platform, headquartered in Sweden. Mecenat is a digitally-led, omni-channel marketplace which connects students, alumni, young professionals and seniors with well-known brands by providing access to exclusive offers, career services and relevant events. Inflexion’s #digital team will work with the business to advance its #technology, data and product offering, which will improve the user experience for members and unlock more value for consumers and brands alike. Inflexion’s significant M&A experience will allow the business to continue with this successful growth strategy, and its international offices will help to identify attractive targets in new markets. ➡️ Read more: https://lnkd.in/eBtkb9H7 #BackingAmbition #AcceleratingGrowth

Inflexion is delighted to announce that it supported 60 acquisitions for its portfolio across 12 countries and six continents in 2024, helping to drive value and accelerate sustainable growth in the UK and internationally. The M&A represents a combined enterprise value of £900m and equates to acquired revenue of £450m. Acquisitive growth has been a key value acceleration strategy for Inflexion since inception, with over 500 completed in the last 25 years and a fifth of them taking place internationally across more than 30 countries. 🌎 ➡️ Read more: https://lnkd.in/eQMZj4TC #BackingAmbition #AcceleratingGrowth

Artificial intelligence and advanced data analytics are revolutionising sales processes, enabling companies to drive #efficiency, boost #productivity, and improve #conversion rates. Discover how Inflexion is working with its portfolio companies to transform their #commercial and #sales strategies with #data and #AI here: https://lnkd.in/dWZJZgvP #BackingAmbition #AcceleratingGrowth CNX Therapeutics Ada Pham Jan Beitner, PhD Jeremy D. Rory Jackson

🎙 New Inflexion point podcast episode out now! 🎙 The latest Inflexion point podcast episode features our portfolio company Medik8, a premium, science-backed #skincare brand, which has gained global acclaim for its results-led approach. In this episode, Medik8 founder Elliot Isaacs and Inflexion's Head of Consumer Tom Pemberton speak to Tim Smallbone about how Elliot formed the idea for the business in the back of his dad's pharmacy, the importance of a scientific and results-led approach, the development of their flagship product; crystal retinal, and what really sets Medik8 apart from the competition. ⚡ 🎧 New episode found here: https://pod.fo/e/28f4c6 🎧 Our previous podcasts which you can listen and subscribe to here: https://lnkd.in/ez5FqpzE #BackingAmbition #AcceleratingGrowth

#Pharmaceuticals companies have long relied on services and firms to support them with innovative products and offerings. In today’s market, the winners will be the providers which can help to optimise #recruitment, streamline operations and overlay #digital enhancements. 🩺 Discover insights from Matthew McCarty, a specialist in advising Life Science Technology businesses, as he explores the increasingly complex and ever-evolving nature of the sector. He also examines current challenges and opportunities and explains how the right private equity firm can support #pharma services and #healthcare technology businesses in achieving success. ➡️ https://lnkd.in/eq6x5Rgc #BackingAmbition #AcceleratingGrowth